1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Market Overview
4.2. Drivers
4.2.1. Increasing Demand for Automation in NGS Workflow
4.2.2. Rising Incidences of Cancer
4.2.3. Increasing R&D Investments and Healthcare Expenditure in Europe
4.3. Restraints
4.3.1. High Cost of Automation Workstations
4.4. Opportunity
4.4.1. Rising Number of Collaborations Between Companies to Develop Library Preparation Protocols
4.4.2. Increasing Applications of Next-Generation Sequencing
4.5. Challenges
4.5.1. Dearth of High-skilled Personnel for Operating Automation Software
4.5.2. Regulatory & Standardization Concerns in Diagnostic Testing
4.6. Pricing Analysis
4.7. Regulatory Analysis
4.8. Porter’s Five Forces Analysis
4.9. Industry and Technology Trends
5. Europe NGS Automation Market Assessment—by Product
5.1. Overview
5.2. Workstations/Robotic Platforms
5.3. Reagents & Consumables
6. Europe NGS Automation Market Assessment—by Application
6.1. Overview
6.2. Drug Discovery
6.3. Clinical Diagnostics
6.3.1. Oncology
6.3.2. Infectious Diseases
6.3.3. Reproductive Health
6.3.4. Other Clinical Diagnostics
6.4. Other Applications
7. Europe NGS Automation Market Assessment—by Sequencing Type
7.1. Overview
7.2. Whole Genome Sequencing
7.3. Whole Exome Sequencing
7.4. Targeted Genome Sequencing
7.5. Other Sequencing Types
8. Europe NGS Automation Market Assessment—by End User
8.1. Overview
8.2. Hospitals & Diagnostic Laboratories
8.3. Pharmaceutical & Biotechnology Companies
8.4. Academics & Research Institutes
8.5. Other End Users
9. Europe NGS Automation Market Assessment—by Geography
9.1. Overview
9.2. Germany
9.3. France
9.4. U.K.
9.5. Italy
9.6. Spain
9.7. Switzerland
9.8. Netherlands
9.9. Belgium
9.10. Rest of Europe (RoE)
10. Competition Analysis
10.1. Overview
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Competitive Dashboard
10.4.1. Industry Leaders
10.4.2. Market Differentiators
10.4.3. Vanguards
10.4.4. Emerging Companies
10.5. Market Share Analysis, by Key Player/Key Market Ranking (2022)
11. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
11.1. Agilent Technologies, Inc.
11.2. Danaher Corporation
11.3. Eppendorf AG
11.4. Hamilton Company
11.5. PerkinElmer, Inc.
11.6. Tecan Group Ltd.
11.7. PRIMADAG SAS
11.8. BRAND GMBH + CO KG
11.9. Hudson Robotics
11.10. SPT Labtech
11.11. Thermo Fisher Scientific, Inc.
11.12. F. Hoffmann-La Roche Ltd
(Note: SWOT analysis will be provided for the top 5 companies only)
12. Appendix
12.1. Available Customization
12.2. Related Reports
List of Tables
Table 1 Europe NGS Automation Market Drivers: Impact Analysis (2024–2030)
Table 2 Europe NGS Automation Market Restraints: Impact Analysis (2024–2030)
Table 3 Europe NGS Automation Market Opportunities: Impact Analysis (2024–2030)
Table 4 Europe NGS Automation Market Challenges: Impact Analysis (2024–2030)
Table 5 NGS Automation Workstation: Pricing Details
Table 6 Europe NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 7 Europe NGS Automation Workstation/Robotic Platform Market, by Country, 2021–2030 (USD Million)
Table 8 Europe NGS Automation Reagents & Consumables Market, by Country, 2021–2030 (USD Million)
Table 9 Europe NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 10 Europe NGS Automation Market for Drug Discovery, by Country, 2021–2030 (USD Million)
Table 11 Europe NGS Automation Market for Clinical Diagnostics, by Type, 2021–2030 (USD Million)
Table 12 Europe NGS Automation Market for Clinical Diagnostics, by Country, 2021–2030 (USD Million)
Table 13 Europe NGS Automation Market for Oncology, by Country, 2021–2030 (USD Million)
Table 14 Europe NGS Automation Market for Infectious Diseases, by Country, 2021–2030 (USD Million)
Table 15 Europe NGS Automation Market for Reproductive Health, by Country, 2021–2030 (USD Million)
Table 16 Europe NGS Automation Market for Other Clinical Diagnostics, by Country, 2021–2030 (USD Million)
Table 17 Europe NGS Automation Market for Other Applications, by Country, 2021–2030 (USD Million)
Table 18 Europe NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 19 Europe NGS Automation Market for Whole Genome Sequencing, by Country, 2021–2030 (USD Million)
Table 20 Europe NGS Automation Market for Whole Exome Sequencing, by Country, 2021–2030 (USD Million)
Table 21 Europe NGS Automation Market for Targeted Genome Sequencing, by Country, 2021–2030 (USD Million)
Table 22 Europe NGS Automation Market for Other Sequencing Types, by Country, 2021–2030 (USD Million)
Table 23 Europe NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 24 Europe NGS Automation Market for Hospitals & Diagnostic Laboratories, by Country, 2021–2030 (USD Million)
Table 25 Europe NGS Automation Market for Pharmaceutical & Biotechnology Companies, by Country, 2021–2030 (USD Million)
Table 26 Europe NGS Automation Market for Academic & Research Institutes, by Country, 2021–2030 (USD Million)
Table 27 Europe NGS Automation Market for Other End Users, by Country, 2021–2030 (USD Million)
Table 28 Europe NGS Automation Market, by Country, 2021–2030 (USD Million)
Table 29 Germany: Key Macro & Micro Indicators
Table 30 Germany: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 31 Germany: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 32 Germany: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 33 Germany: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 34 Germany: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 35 France: Key Macro & Micro Indicators
Table 36 France: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 37 France: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 38 France: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 39 France: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 40 France: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 41 U.K.: Key Macro & Micro Indicators
Table 42 U.K.: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 43 U.K.: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 44 U.K.: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 45 U.K.: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 46 U.K.: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 47 Italy: Key Macro & Micro Indicators
Table 48 Italy: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 49 Italy: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 50 Italy: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 51 Italy: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 52 Italy: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 53 Spain: Key Macro & Micro Indicators
Table 54 Spain: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 55 Spain: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 56 Spain: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 57 Spain: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 58 Spain: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 59 Switzerland: Key Macro & Micro Indicators
Table 60 Switzerland: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 61 Switzerland: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 62 Switzerland: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 63 Switzerland: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 64 Switzerland: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 65 Netherlands: Key Macro & Micro Indicators
Table 66 Netherlands: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 67 Netherlands: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 68 Netherlands: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 69 Netherlands: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 70 Netherlands: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 71 Belgium: Key Macro & Micro Indicators
Table 72 Belgium: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 73 Belgium: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 74 Belgium: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 75 Belgium: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 76 Belgium: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 77 Rest of Europe: NGS Automation Market, by Product, 2021–2030 (USD Million)
Table 78 Rest of Europe: NGS Automation Market, by Application, 2021–2030 (USD Million)
Table 79 Rest of Europe: Clinical Diagnostics Market, by Type, 2021–2030 (USD Million)
Table 80 Rest of Europe: NGS Automation Market, by Sequencing Type, 2021–2030 (USD Million)
Table 81 Rest of Europe: NGS Automation Market, by End User, 2021–2030 (USD Million)
Table 82 Recent Developments, by Company (2019–2022)
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Europe NGS Automation Market, by Product, 2024 Vs. 2030 (USD Million)
Figure 8 Europe NGS Automation Market, by Application, 2024 Vs. 2030 (USD Million)
Figure 9 Europe NGS Automation Market, by Sequencing Type, 2024 Vs. 2030 (USD Million)
Figure 10 Europe NGS Automation Market, by End User, 2024 Vs. 2030 (USD Million)
Figure 11 Market Dynamics: Europe NGS Automation Market
Figure 12 Europe NGS Automation Market, by Product, 2024 Vs. 2030 (USD Million)
Figure 13 Europe NGS Automation Market, by Application, 2024 Vs. 2030 (USD Million)
Figure 14 Europe NGS Automation Market, by Sequencing Type, 2024 Vs. 2030 (USD Million)
Figure 15 Europe NGS Automation Market, by End User, 2024 Vs. 2030 (USD Million)
Figure 16 Europe: NGS Automation Market Snapshot
Figure 17 Key Growth Strategies Adopted by Leading Players (2020–2024)
Figure 18 Europe NGS Automation Market: Competitive Benchmarking Based on Product
Figure 19 Europe NGS Automation Market: Competitive Benchmarking Based on Country
Figure 20 Europe NGS Automation Market: Competitive Dashboard
Figure 21 Market Share Analysis: Europe NGS Automation Market (2022)
Figure 22 Agilent Technologies, Inc.: Financial Overview (2021)
Figure 23 Danaher Corporation: Financial Overview (2021)
Figure 24 Eppendorf AG: Financial Overview (2020)
Figure 25 PerkinElmer, Inc.: Financial Overview (2020)
Figure 26 Tecan Group Ltd.: Financial Overview (2020)
Figure 27 Thermo Fisher Scientific, Inc.: Financial Overview (2021)
Figure 28 F. Hoffmann-La Roche Ltd: Financial Overview (2021)